Skip to main content
. Author manuscript; available in PMC: 2014 Aug 25.
Published in final edited form as: Procedia Vaccinol. 2014 Jan 1;8:38–42. doi: 10.1016/j.provac.2014.07.007

Figure 3. Bps OMV-specific IgG in plasma of immunized NHPs.

Figure 3

OMV-, LPS-, and CPS-specific plasma IgG isshown for pre-immune samples as well as samples obtained after a primary immunization with 25μg, a boost with 50μg, and a second boost with 100μg of OMV vaccine admixed with CpG. Control animals received 400µg of CpG only at each immunization point. IN71, II81 – OMV-immunized; HM73, DJ17 – controls.